Literature DB >> 17131231

Dystonia in Parkinson's disease.

Eduardo Tolosa1, Yaroslau Compta.   

Abstract

Dystonia can occasionally be found in idiopathic Parkinson's disease. It is very uncommon in untreated patients and is more frequently seen as a complication of its treatment. In this review, the various types of dystonia occurring in PD, the differential diagnosis with other parkinsonian syndromes associated with dystonia and treatments available are revised. Dystonia unrelated to treatment can be typical (blepharospasm, torticollis), atypical (parkinsonian writer's cramp, camptocormia, anismus), or occurring in earlyonset Parkinson disease (the so-called kinesigenic foot dystonia, considered a hallmark of early-onset Parkinson's disease). Early and prominent dystonia in untreated patients with parkinsonism should raise the suspicion of other entities other than Parkinson's disease, such as progressive supranuclear palsy, multiple system atrophy or corticobasal degeneration. In patients on chronic dopaminergic treatment, peak-dose dystonia, diphasic dystonia and off-dystonia can be seen. The later constitutes the major dystonic feature of chronic levodopa therapy, and a wide variety of strategies are available to manage this complication. Among them, deep brain stimulation of the subthalamic nucleus has proved to be the most effective one. Dystonic reactions (mainly involving oculomotor cranial nerves and limbs) in operated patients (especially carriers of deep brain stimulation (DBS) devices) are increasingly being reported, constituting a new type of dystonia in patients with Parkinson's disease: dystonia linked to surgical treatment.

Entities:  

Mesh:

Year:  2006        PMID: 17131231     DOI: 10.1007/s00415-006-7003-6

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  71 in total

1.  Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease.

Authors:  V Fraix; P Pollak; N Van Blercom; J Xie; P Krack; A Koudsie; A L Benabid
Journal:  Neurology       Date:  2000-12-26       Impact factor: 9.910

2.  Phenomenology of "Lubag" or X-linked dystonia-parkinsonism.

Authors:  Virgilio Gerald H Evidente; Joel Advincula; Raymund Esteban; Paul Pasco; Jhoe Anthony Alfon; Filipinas F Natividad; Joven Cuanang; Amado San Luis; Katrina Gwinn-Hardy; John Hardy; Dena Hernandez; Andrew Singleton
Journal:  Mov Disord       Date:  2002-11       Impact factor: 10.338

Review 3.  Dystonia in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.

Authors:  J Rivest; N Quinn; C D Marsden
Journal:  Neurology       Date:  1990-10       Impact factor: 9.910

Review 4.  Apraxia in movement disorders.

Authors:  Cindy Zadikoff; Anthony E Lang
Journal:  Brain       Date:  2005-06-01       Impact factor: 13.501

5.  Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?

Authors:  B P Bejjani; I Arnulf; S Demeret; P Damier; A M Bonnet; J L Houeto; Y Agid
Journal:  Ann Neurol       Date:  2000-05       Impact factor: 10.422

6.  Park7, a novel locus for autosomal recessive early-onset parkinsonism, on chromosome 1p36.

Authors:  C M van Duijn; M C Dekker; V Bonifati; R J Galjaard; J J Houwing-Duistermaat; P J Snijders; L Testers; G J Breedveld; M Horstink; L A Sandkuijl; J C van Swieten; B A Oostra; P Heutink
Journal:  Am J Hum Genet       Date:  2001-07-02       Impact factor: 11.025

7.  Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.

Authors:  M C Rodriguez-Oroz; J A Obeso; A E Lang; J-L Houeto; P Pollak; S Rehncrona; J Kulisevsky; A Albanese; J Volkmann; M I Hariz; N P Quinn; J D Speelman; J Guridi; I Zamarbide; A Gironell; J Molet; B Pascual-Sedano; B Pidoux; A M Bonnet; Y Agid; J Xie; A-L Benabid; A M Lozano; J Saint-Cyr; L Romito; M F Contarino; M Scerrati; V Fraix; N Van Blercom
Journal:  Brain       Date:  2005-06-23       Impact factor: 13.501

8.  Not paralysis, but dystonia causes stridor in multiple system atrophy.

Authors:  Ilaria Maria Merlo; Antonio Occhini; Claudio Pacchetti; Enrico Alfonsi
Journal:  Neurology       Date:  2002-02-26       Impact factor: 9.910

9.  Controlled release levodopa-carbidopa (CR-5) in the management of parkinsonian motor fluctuations.

Authors:  J L Juncos; G Fabbrini; M M Mouradian; T N Chase
Journal:  Arch Neurol       Date:  1987-10

10.  Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes.

Authors:  V Bonifati; C F Rohé; G J Breedveld; E Fabrizio; M De Mari; C Tassorelli; A Tavella; R Marconi; D J Nicholl; H F Chien; E Fincati; G Abbruzzese; P Marini; A De Gaetano; M W Horstink; J A Maat-Kievit; C Sampaio; A Antonini; F Stocchi; P Montagna; V Toni; M Guidi; A Dalla Libera; M Tinazzi; F De Pandis; G Fabbrini; S Goldwurm; A de Klein; E Barbosa; L Lopiano; E Martignoni; P Lamberti; N Vanacore; G Meco; B A Oostra
Journal:  Neurology       Date:  2005-07-12       Impact factor: 9.910

View more
  55 in total

Review 1.  Convergent mechanisms in etiologically-diverse dystonias.

Authors:  Valerie B Thompson; H A Jinnah; Ellen J Hess
Journal:  Expert Opin Ther Targets       Date:  2011-12-03       Impact factor: 6.902

Review 2.  Hand, foot, and spine deformities in parkinsonian disorders.

Authors:  Subhashie Wijemanne; Joseph Jankovic
Journal:  J Neural Transm (Vienna)       Date:  2019-02-27       Impact factor: 3.575

Review 3.  The functional neuroanatomy of dystonia.

Authors:  Vladimir K Neychev; Robert E Gross; Stephane Lehéricy; Ellen J Hess; H A Jinnah
Journal:  Neurobiol Dis       Date:  2011-02-12       Impact factor: 5.996

4.  Two cases of early dystonia of the trunk in Parkinson's disease.

Authors:  Natascia Beretta; Emmanuel Roze; Christine Breifel-Courbon; Marie Vidailhet
Journal:  J Neurol       Date:  2015-05-01       Impact factor: 4.849

Review 5.  Diagnosis and treatment of dystonia.

Authors:  H A Jinnah; Stewart A Factor
Journal:  Neurol Clin       Date:  2015-02       Impact factor: 3.806

6.  Severe Jaw-Opening Dystonia as an Unusual Manifestation of Levodopa-Related Wearing-Off in Parkinson's Disease, and Successful Treatment With Botulinum Toxin Injection.

Authors:  Pankaj Ashok Agarwal
Journal:  Mov Disord Clin Pract       Date:  2019-05-29

7.  Muscle Contraction as a False Localizing Sign During Intraoperative Macrostimulation of Subthalamic Nucleus.

Authors:  Gian D Pal; Sepehr Sani; Leo Verhagen
Journal:  Mov Disord Clin Pract       Date:  2015-02-24

8.  Association of TOR1A and GCH1 Polymorphisms with Isolated Dystonia in India.

Authors:  Subhajit Giri; Arunibha Ghosh; Shubhrajit Roy; Charulata Savant Sankhla; Shyamal Kumar Das; Kunal Ray; Jharna Ray
Journal:  J Mol Neurosci       Date:  2020-07-13       Impact factor: 3.444

9.  GCH1 mutations in dopa-responsive dystonia and Parkinson's disease.

Authors:  Hiroyo Yoshino; Kenya Nishioka; Yuanzhe Li; Yutaka Oji; Genko Oyama; Taku Hatano; Yutaka Machida; Yasushi Shimo; Arisa Hayashida; Aya Ikeda; Kaoru Mogushi; Yasuro Shibagaki; Ai Hosaka; Hiroshi Iwanaga; Junko Fujitake; Takekazu Ohi; Daigo Miyazaki; Yoshiki Sekijima; Mitsuaki Oki; Hirofumi Kusaka; Ken-Ichi Fujimoto; Yoshikazu Ugawa; Manabu Funayama; Nobutaka Hattori
Journal:  J Neurol       Date:  2018-06-14       Impact factor: 4.849

Review 10.  Motor Complications of Dopaminergic Medications in Parkinson's Disease.

Authors:  Maria Eliza Freitas; Christopher W Hess; Susan H Fox
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.